The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
Tools
Hatzimichael, E, Dasoula, A, Shah, R, Syed, N, Papoudou-Bai, A, Coley, HM, Dranitsaris, G, Bourantas, KL, Stebbing, J and Crook, T (2010) The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia EUROPEAN JOURNAL OF HAEMATOLOGY, 84 (1). pp. 47-51.
Full text not available from this repository.Item Type: | Article | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Divisions : | Surrey research (other units) | |||||||||||||||||||||||||||||||||
Authors : |
|
|||||||||||||||||||||||||||||||||
Date : | 1 January 2010 | |||||||||||||||||||||||||||||||||
DOI : | 10.1111/j.1600-0609.2009.01344.x | |||||||||||||||||||||||||||||||||
Uncontrolled Keywords : | Science & Technology, Life Sciences & Biomedicine, Hematology, HEMATOLOGY, multiple myeloma, plasma cell neoplasia, methylation, EGLN1, EGLN3, prolyl-hydroxylase, MULTIPLE-MYELOMA, TUMOR-SUPPRESSOR, CANCER, HYPOXIA, DISEASE, GROWTH, FAMILY, GENE, HIF | |||||||||||||||||||||||||||||||||
Related URLs : | ||||||||||||||||||||||||||||||||||
Depositing User : | Symplectic Elements | |||||||||||||||||||||||||||||||||
Date Deposited : | 17 May 2017 08:59 | |||||||||||||||||||||||||||||||||
Last Modified : | 24 Jan 2020 15:40 | |||||||||||||||||||||||||||||||||
URI: | http://epubs.surrey.ac.uk/id/eprint/821742 |
Actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year